Catherine has over 25 years of experience in biotech, pharmaceutical and as a venture investor. She is currently the CEO of Exonate for which she was one of the founders leading the spin-out from Nottingham University. Catherine has a degree in medicine
from Birmingham University and in 2008 was awarded the OBE for services to technology and innovation.